AbbVie Inc. - 8-K Filing
AbbVie Inc. filed to report the results of its 2026 Annual Meeting of Stockholders held on May 8, 2026. The stockholders elected four Class II directors with terms expiring in 2029 and ratified Ernst & Young LLP as the independent registered public accounting firm for 2026. Proposals to eliminate supermajority voting requirements and adopt a policy requiring an independent chair were not approved.
Tickers: $ABBV